ASCO 2019: Right to Try Legislation and Why Clinical Trial Entry Criteria Need to Change

ASCO 2019: Right to Try Legislation and Why Clinical Trial Entry Criteria Need to Change

Dr. Kelly Shanahan, independent patient advocate, explains Right to Try and Compassionate Use legislation.
Jun 19, 2019
/_next/static/media/art.743baba8.png
00:00
Download
00:00

Dr. Shanahan was part of a panel on Right to Try Legislation at the 2019 American Society of Clinical Oncology Annual Meeting. In this podcast, she explains Right to Try and Compassionate Use legislation and why she thinks the real answer is changing the criteria for enrolling in clinical trials.

Listen to the podcast to hear Dr. Shanahan talk about:

  • why she thinks Right to Try legislation is flawed

  • how the common criteria for entering a clinical trial exclude a majority of people diagnosed with metastatic disease and how trials can be changed

  • how she would proceed if her disease progressed and she didn't meet the eligibility criteria for an appropriate clinical trial

About the guest
 
Kelly Shanahan, MD

Dr. Kelly Shanahan is a metastatic patient advocate and METAvivor board member. She had to give up her OB/GYN practice because of side effects from metastatic breast cancer treatment.

— Last updated on June 29, 2022, 2:49 PM

 
Lilly

This content made possible by Lilly Oncology.

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate